Deregulation of SIRT1 in CML LSCs promotes the drug resistance and of in CML LSCs by deacetylating many transcription factors, including p53, Ku70, and FOXO151,52. This evidence concerns the gene TP53 and chronic myelogenous leukemia, BCR-ABL1 positive.